Adicet Bio, Inc. (ACET) vs Verrica Pharmaceuticals Inc. (VRCA)

Adicet Bio, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Adicet Bio, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($77.4M and $74.9M). Adicet Bio, Inc. grew revenue faster over the last twelve months: 224.6% against 106.2%. Adicet Bio, Inc. has the higher net margin (0.00% vs −102.8%) and the lower return on invested capital (−2,518.2% vs 0.00%). Across the 17 metrics below, Adicet Bio, Inc. leads on 11 and Verrica Pharmaceuticals Inc. on 6.

Valuation

Metric ACET VRCA Biotechnology median
P/E n/m n/m 7.88
P/S 2.50 3.07 11.47
P/B 0.81 21.62 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales (0.53) 3.14 10.73
Earnings yield (126.94%) (38.22%) (28.84%)
Free cash flow yield (87.66%) (14.60%) (23.03%)

Profitability

Metric ACET VRCA Biotechnology median
Gross margin 0.00% 85.89% 65.16%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity (78.08%) 473.29% (57.72%)
Return on assets (63.62%) (83.02%) (49.22%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET VRCA Biotechnology median
Revenue growth (TTM) 224.62% 106.21% 5.64%
EPS growth (last fiscal year) 20.35% 88.65% —
Revenue growth, 5-year CAGR 6.90% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACET VRCA Biotechnology median
Debt to equity 0.01 0.18 0.00
Current ratio 6.71 1.45 4.73
Net debt to EBITDA 1.32 2.59 0.96

Dividend

Metric ACET VRCA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACET VRCA Biotechnology median
Market cap 77.42m 74.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack